Статус: | Completed |
Фаза: | N/A |
Начало: | 17 марта 2022 г. |
Окончание: | 20 июля 2022 г. |
Описание: | Pharmacokinetics, safety and efficacy study of GP30341, 200 mg capsules (GEROPHARM LLC, Russia) in healthy volunteers and patients with novel coronavirus infection 2019 (COVID-19) with a high risk of adverse outcome |
смотреть на ClinicalTrials.gov |